Supplement's "enhancement" drives recall

Novacare is recalling all lots of a male sexual enhancement supplement distributed before mid-June. The recall follows the FDA's finding that the products--encompassing some 21 imaginatively named brands--"appear to contain sulfoaildenafil," which is undeclared on the labels. Sulfoaildenafil is a cousin to Sildenafil, more commonly known as Viagra. The products were distributed in bottles and blister cards to brick-and-mortar and online retailers. Recall notice 

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.